These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35752528)

  • 1. Cardiovascular events after a dramatic reduction of HbA1c in hospitalized subjects with type 2 diabetes and high long-term glucose exposure.
    Rigalleau V; Larroumet A; Ducos C; Rigo M; Barbet-Massin MA; Majchrzak C; Mohammedi K; Baillet-Blanco L; Monlun M; Rami-Arab L; Foussard N
    J Diabetes Complications; 2022 Aug; 36(8):108234. PubMed ID: 35752528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
    Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
    Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes.
    Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR
    BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
    Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
    Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
    Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
    Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.
    van der Heyden JC; Birnie E; Mul D; Bovenberg S; Veeze HJ; Aanstoot HJ
    BMC Endocr Disord; 2016 Sep; 16(1):49. PubMed ID: 27613110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. For diabetic type 1 patients, the skin autofluorescence predicts ulcers and amputations.
    Rojubally S; Simoneau A; Monlun M; Foussard N; Blanco L; Domenge F; Mohammedi K; Ducasse E; Caradu C; Rigalleau V
    J Diabetes Complications; 2021 Mar; 35(3):107808. PubMed ID: 33386214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.
    Rajaobelina K; Helmer C; Vélayoudom-Céphise FL; Nov S; Farges B; Pupier E; Blanco L; Hugo M; Gin H; Rigalleau V
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin autofluorescence and glycemic variability.
    Noordzij MJ; Lefrandt JD; Graaff R; Smit AJ
    Diabetes Technol Ther; 2010 Jul; 12(7):581-5. PubMed ID: 20597834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes.
    Bentata R; Cougnard-Grégoire A; Delyfer MN; Delcourt C; Blanco L; Pupier E; Rougier MB; Rajaobelina K; Hugo M; Korobelnik JF; Rigalleau V
    J Diabetes Complications; 2017 Mar; 31(3):619-623. PubMed ID: 28063765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.
    van Waateringe RP; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Paterson AD; Lutgers HL; Wolffenbuttel BH
    Eur J Clin Invest; 2016 May; 46(5):481-90. PubMed ID: 27002914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
    Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
    J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus.
    de Ranitz-Greven WL; Kaasenbrood L; Poucki WK; Hamerling J; Bos DC; Visser GH; Biesma DH; Beulens JW; de Valk HW
    Diabetes Technol Ther; 2012 Dec; 14(12):1134-9. PubMed ID: 23113747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy in well-controlled type 2 diabetes: Role of glycaemic memory.
    Ducos C; Rigo M; Larroumet A; Delyfer MN; Korobelnik JF; Monlun M; Foussard N; Poupon P; Haissaguerre M; Blanco L; Mohammedi K; Rigalleau V
    Diabetes Metab; 2021 Feb; 47(1):101156. PubMed ID: 32387701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease.
    Rezende PC; Hlatky MA; Hueb W; Garcia RMR; da Silva Selistre L; Lima EG; Garzillo CL; Scudeler TL; Boros GAB; Ribas FF; Serrano CV; Ramires JAF; Kalil Filho R
    JAMA Netw Open; 2020 Jan; 3(1):e1919666. PubMed ID: 31968117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA
    Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M
    Diabetologia; 2021 Nov; 64(11):2402-2414. PubMed ID: 34448033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease.
    Bots SH; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle JL; Visseren FL; Westerink J;
    Cardiovasc Diabetol; 2016 Jul; 15(1):101. PubMed ID: 27431507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes.
    Maran A; Morieri ML; Falaguasta D; Avogaro A; Fadini GP
    Diabetes Care; 2022 Oct; 45(10):2439-2444. PubMed ID: 35972256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end products as predictors of renal function in youth with type 1 diabetes.
    Forbes JM; Le Bagge S; Righi S; Fotheringham AK; Gallo LA; McCarthy DA; Leung S; Baskerville T; Nisbett J; Morton A; Teasdale S; D'Silva N; Barrett H; Jones T; Couper J; Donaghue K; Isbel N; Johnson DW; Donnellan L; Deo P; Akison LK; Moritz KM; O'Moore-Sullivan T
    Sci Rep; 2021 May; 11(1):9422. PubMed ID: 33941808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.